NCT06306859

Brief Summary

One of the goals in the Sustainable Development Goals (SDGs) is the availability of a healthy and prosperous life for all ages. This goal mentions health priorities i.e. non-communicable diseases. Chronic kidney failure (CRF) is one of the non-communicable diseases that is the main cause of death and disability both in the world and in Indonesia. The prevalence of CRF in Indonesia is 0.5% with 83.2% of patients being of productive age and the highest number of CRF patients in North Kalimantan, Southeast Sulawesi, DKI Jakarta and Yogyakarta. Monitoring and evaluation of patients with CRF is currently mostly carried out conventionally not using health technology that is integrated with hospital information systems. This study aims to design and provide a health information system for patients with CRF, hereinafter referred to as SIKIDI, which integrates mobile-health applications used independently by patients with existing information systems in hospitals.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable quality-of-life

Timeline
Completed

Started Mar 2024

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 4, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

March 12, 2024

Completed
3 days until next milestone

Study Start

First participant enrolled

March 15, 2024

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

March 12, 2024

Status Verified

March 1, 2024

Enrollment Period

8 months

First QC Date

March 4, 2024

Last Update Submit

March 11, 2024

Conditions

Keywords

Quality of lifeself efficacychronic kidney disease

Outcome Measures

Primary Outcomes (1)

  • Quality of Life that will be measured using KDQOL before and after intervention

    The quality of life will be measured using Kidney Disease Quality of Life, (KDQOL) before and after the intervention. The max score is 100 and minimum score is 50

    four weeks

Secondary Outcomes (1)

  • Self-efficacy that will be measured using CKD SE before and after

    four weeks

Study Arms (2)

SIKIDI group

EXPERIMENTAL

The experimental arm will be given to access to m-health to monitor and education provision.

Behavioral: Using m-health for monitoring and education provision

Comparator

ACTIVE COMPARATOR

The comparator group will be given standard care

Other: Standard care

Interventions

The intervention group will be given access to m-health. The m-health aims to monitor patient's status i.e blood pressure, heart rate, fluid intake, dietary intake. In addition, there will be education provided through the m-health. The education will be on fluid and diet adherence

SIKIDI group

The comparator group will be given standard and routine care

Comparator

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \>18 years old
  • has been undergoing hemodialysis \>3 months
  • has smartphone

You may not qualify if:

  • emergency hemodialysis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

RS PKU Muhammadiyah Bantul

Bantul, Yogy, 55183, Indonesia

Location

MeSH Terms

Conditions

Renal Insufficiency, Chronic

Interventions

Standard of Care

Condition Hierarchy (Ancestors)

Renal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
The sample will be divided based on the schedule of hemodialysis. Intervention group will be chosen from Monday-Thursday.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The intervention group will be given access to m-health to monitor and education provision for about four weeks
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr

Study Record Dates

First Submitted

March 4, 2024

First Posted

March 12, 2024

Study Start

March 15, 2024

Primary Completion

October 31, 2024

Study Completion

December 31, 2024

Last Updated

March 12, 2024

Record last verified: 2024-03

Locations